Microvascular Dysfunction in Ischemia with No Obstructive Coronary Arteries (INOCA): Pathophysiology, Diagnosis, and

Sidhartha Senapati1, Joel Shah1, Lakshmi Kattamuri1

  • 1Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA.

Insights

Ischemia with No Obstructive Coronary Arteries (INOCA) involves small vessel dysfunction, not main artery blockages. Identifying INOCA type with specific tests improves angina management and quality of life.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Ischemia with No Obstructive Coronary Arteries (INOCA) presents as angina and reduced blood flow despite clear major coronary arteries.
  • This condition often stems from underlying microvascular dysfunction, inflammation, or oxidative stress.

Purpose of the Study:

  • To synthesize current understanding of Ischemia with No Obstructive Coronary Arteries (INOCA) based on recent literature.
  • To highlight diagnostic modalities and therapeutic strategies for INOCA.

Main Methods:

  • Systematic literature review of studies published between January 2018 and December 2025.
  • Inclusion of research on Coronary Flow Reserve (CFR), Index of Microcirculatory Resistance (IMR), and novel treatments for INOCA.

Main Results:

  • Coronary Microvascular Dysfunction (CMD) in INOCA can be attributed to endothelial dysfunction, inflammation, and oxidative stress.
  • Diagnostic tools include noninvasive Cardiac Magnetic Resonance (CMR) and invasive assessments like CFR < 2.5, IMR ≥ 25, and acetylcholine provocation.
  • Pharmacological treatments such as statins, ACE inhibitors/ARBs, calcium-channel blockers, trimetazidine, and ranolazine can alleviate angina and enhance quality of life.

Conclusions:

  • INOCA is characterized by small vessel abnormalities, often missed by standard angiography, necessitating specialized diagnostic approaches.
  • Utilizing tests like CFR, IMR, and acetylcholine provocation aids in accurate INOCA diagnosis and tailored treatment strategies.
  • Personalized treatment based on INOCA subtype significantly improves patient outcomes, reducing angina and enhancing quality of life.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
954
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
68
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
627